Jan 3, 2024 | Artificial Intelligence, Prescription, Research
According to a Long Island University study, artificial intelligence tool ChatGPT’s answers to nearly 75% of drug-related questions were incomplete or wrong… and in some cases, even generated fake citations to support its answers. Researchers challenged the free...
Jan 2, 2024 | Biometric recognition, Claims, Drug costs, Flexible spending accounts (FSAs), Health Benefits, Health reimbursement arrangements (HRAs), ID Card, MedBen Access, Mobile App, Online Services, Wellness
Based on client survey feedback, some plan members aren’t aware that MedBen offers a mobile app… so we’ve created a flyer to help spread the word! MedBen Access has long been available online, but for those who prefer smartphone convenience, the...
Dec 26, 2023 | Alternative Reimbursement Strategies, Benefits preservation, Client Feedback, Client Surveys, Fair Market Pricing, ISO, Kurt Harden, MedBen Connect, MedBen Rx, President's Note
On behalf of the MedBen team, I wish you a happy and prosperous new year and thank you for your continued trust in MedBen. In 2023, we celebrated our 85th Anniversary. Those years have been marked by a variety of challenges and successes but I am particularly...
Dec 22, 2023 | Acquisition Cost Index (ACI) pricing, Cost Plus Pricing, Cost Savings, Drug costs, MedBen Rx, Pharmacy, Prescription, Rx Costs, Savings, Spread Pricing
Spread pricing is the difference between what pharmacy benefit managers (PBMs) charge health plans for drugs and what the pharmacy actually pays for them. Often, this “spread” can be substantial, as PBMs profit greatly from their lack of transparency… so it’s not...
Dec 21, 2023 | Announcements, Compliance, Independent Dispute Resolution (IDR), No Surprises Act (NSA), Regulatory
This past August, a federal court in the Eastern District of Texas vacated certain portions of regulatory guidance establishing the fees charged under the No Surprises Act (NSA) Independent Dispute Resolution (IDR) process. In response to the court’s Order, on...
